Recent studies have also suggested potential renal benefits, such as reducing albuminuria (a marker of kidney disease), although more research is required in this area
Besides, the relative contribution of each APAP metabolic reaction was investigated (Table 1)
However, as major multinational pharmaceutical companies like Novo Nordisk and Eli Lilly have reaped significant rewards in the GLP-1 market, Merck may have realized the need for a more aggressive strategy to stay competitive
Neurosci Res (2012) 74(2):13843.10.1016/j.neures.2012.08.002 137 KellettGL
We are located at 1451 River Park Drive, Suite 210 Sacramento, CA 95815
It is not FDA-approved, so it can be dosed only in research settings and is typically injected daily for a short study duration at doses between 250mcg and 1mg [13, 14, 18, 19]